Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
European VC Medicxi closes €500M biotech fund
The new oversubscribed fund follows the European firm’s $400 million fund raised back in 2023.
Gabrielle Masson
Nov 14, 2025 3:00am
Lilly continues AI push, inking $100M-plus deal with Insilico
Nov 10, 2025 9:00am
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds
Nov 10, 2025 4:05am
Recursion refreshes leadership with CEO swap—Chutes & Ladders
Nov 7, 2025 8:30am
FDA reveals 2nd round of 'national priority' voucher winners
Nov 6, 2025 3:12pm
